Skip to main content
Fig. 7 | Cellular & Molecular Biology Letters

Fig. 7

From: Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival

Fig. 7

(data source: in BC patients receiving different therapeutic modalities. f BC patients receiving chemotherapy. g BC patients receiving endocrine therapy. h BC patients receiving anti-HER2+ therapy

Prognostic and predictive role of CDKN2B-AS1 gene in breast cancer (BC). ae Kaplan–Meier plots for BC patients according to their molecular subtypes (Data source: KMplotter). a Overall analysis. b Luminal A. c Luminal B. d HER2+. e Basal-like BC subtype. fh Comparison of CDKN2B-AS1 expression level between responder and non-responder and analysis of relapse-free survival at 5 years.

Back to article page